¼¼°èÀÇ ´ëµ¿¸Æ³» ÀÌ½ÄÆí ½ÃÀå º¸°í¼­(2025³â)
Aortic Endograft Global Market Report 2025
»óǰÄÚµå : 1681745
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,342,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,167,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,992,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ëµ¿¸Æ³» ÀÌ½ÄÆí ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö 4.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 42¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº º¹ºÎ ´ëµ¿¸Æ·ù À¯º´·ü Áõ°¡, ÃÖ¼Ò Ä§½ÀÀû Ç÷°ü ³» Ä¡·á ¼±È£µµ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ½ºÅÙÆ® ÀÌ½Ä Àç·á ¹× ±¸¼ºÀÇ ¹ßÀü, »õ·Î¿î ½ºÅÙÆ® ÀÌ½Ä Á¦Ç°ÀÇ µµÀÔ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Ç÷°ü ³» º¹ºÎ ´ëµ¿¸Æ·ù(AAA) Ä¡·á ÀåÄ¡ÀÇ Ã¤ÅÃ, À¯´Ï¹Ùµð ¹× ºñÀ¯´Ï¹Ùµð ´ëµ¿¸Æ ½ºÅÙÆ®ÀÇ È¿°ú, Á¦Ç° Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

´ëµ¿¸Æ·ù À¯º´·ü Áõ°¡´Â ´çºÐ°£ ´ëµ¿¸Æ³» ÀÌ½ÄÆí ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Åü¿¡¼­ °¡Àå Å« µ¿¸ÆÀÎ ´ëµ¿¸ÆÀÇ ºñÁ¤»óÀûÀÎ È®ÀåÀ» Ư¡À¸·Î ÇÏ´Â ´ëµ¿¸Æ·ù´Â ±âÁ¸ÀÇ °³º¹ ¼ö¼ú¿¡ ºñÇØ ´ú ħ½ÀÀûÀÎ °ÍÀ¸·Î ¾Ë·ÁÁø ´ëµ¿¸Æ ³»½Ã°æÀ» »ç¿ëÇÏ¿© È¿°úÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î õÀ¸·Î µ¤ÀÎ ±Ý¼Ó ¶Ç´Â Æú¸®¸Ó·Î ±¸¼ºµÈ ÀÌ ±â±¸´Â Ä«Å×Å͸¦ ÅëÇØ »ðÀÔµÇ¾î ¾àÇØÁø ´ëµ¿¸Æ º®À» º¸°­ÇÏ°í ÆÄ¿­ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. 2023³â 2¿ù ¿µ±¹¿¡ ±â¹ÝÀ» µÐ Á¤ºÎ µðÁöÅÐ ¼­ºñ½ºÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2021³â 4¿ùºÎÅÍ 2022³â 3¿ù±îÁö ¾à 274,800¸íÀÇ ³²¼ºÀÌ °ËÁøÀ» ¹Þ¾Ò°í 79.0%°¡ È®Áø ÆÇÁ¤À» ¹Þ¾ÒÀ¸¸ç, 2021³â 4¿ùºÎÅÍ 2022³â 3¿ù±îÁö 1,794°³ÀÇ µ¿¸Æ·ù°¡ ¹ß°ßµÇ¾ú½À´Ï´Ù´Â »ç½ÇÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ¹ß°ßµÇ¾ú½À´Ï´Ù´Â °ÍÀÔ´Ï´Ù. ÀÌ´Â ´ëµ¿¸Æ·ù À¯º´·ü Áõ°¡°¡ ´ëµ¿¸Æ³» ÀÌ½ÄÆí ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ½À» µÞ¹ÞħÇÕ´Ï´Ù.

´ëµ¿¸Æ³» ÀÌ½ÄÆí ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ij½ºÅÍ ºÐÁöÇü ´ëµ¿¸Æ ½ºÅÙÆ® ÀÌ½Ä ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇÏ¿© ¾÷°è¿¡¼­ °æÀï·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ij½ºÅÍ ºÐÁöÇü ´ëµ¿¸Æ ½ºÅÙÆ® ÀÌ½Ä ½Ã½ºÅÛÀº ´ëµ¿¸Æ°ú ´ëµ¿¸Æ±ÃÀÇ ÃÖ¼Ò Ä§½ÀÀû ¼ö¸®, ƯÈ÷ ½ºÅÄÆ÷µå BÇü ´ëµ¿¸Æ ¹Ú¸®(TBAD)¸¦ À§ÇØ °í¾ÈµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 8¿ù, ÅÚ¸ð ÄÚÆÛ·¹À̼ÇÀÇ Àεµ ÀÚȸ»çÀÌÀÚ Áß¿äÇÑ ÀÇ·á ±â¼ú ±â¾÷ÀÎ ÅÚ¸ð Àεµ´Â Ç÷°ü ³» µ¿¸Æ·ù Ä¡·á(EVAR)¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÎ TREO ½ºÅÙÆ® ÀÌ½Ä ½Ã½ºÅÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ã·´Ü ½Ã½ºÅÛÀº ÀûÀýÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ °¡Áø ¼ºÀÎÀÇ ½ÅÀå ³» º¹ºÎ ´ëµ¿¸Æ·ù Ä¡·á¸¦ ¸ñÀûÀ¸·Î Çϸç, ½ÅÀå »óºÎ ¹× ½ÅÀå ÇϺΠ¸ðµÎ¿¡¼­ ´Éµ¿Àû °íÁ¤ÀÌ °¡´ÉÇÑ À¯ÀÏÇÑ EVAR À̽ÄÀÓº£µðµå´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª19¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

An aortic endograft, also known as an endovascular stent graft, is a minimally invasive medical device designed to repair weakened areas of the aorta, the primary artery responsible for transporting blood from the heart to the rest of the body. This device serves as an alternative to traditional open surgery for treating aortic aneurysms.

The primary categories of aortic endografts include abdominal aortic grafts and thoracic aortic grafts. Abdominal aortic grafts are specifically implanted in the abdominal aorta to address aneurysms by reinforcing weakened arterial walls. These devices can be made from materials such as metallic endografts and polymeric endografts, and the procedures involved include open surgical repair and endovascular aneurysm repair (EVAR). Aortic endografts are commonly utilized in medical settings, including hospitals and ambulatory surgical centers.

The aortic endografts market research report is one of a series of new reports from The Business Research Company that provides aortic endografts market statistics, including aortic endografts industry global market size, regional shares, competitors with aortic endografts market share, detailed aortic endografts market segments, market trends, and opportunities, and any further data you may need to thrive in the aortic endografts industry. This aortic endografts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The aortic endograft market size has grown strongly in recent years. It will grow from $3.35 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to growth in medical tourism, increasing need for aortic aneurysm management, increasing number of aortic aneurysm cases, technical success of endograft implantation, increase in the number of hospitals.

The aortic endograft market size is expected to see steady growth in the next few years. It will grow to $4.27 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.

The increasing prevalence of aortic aneurysms is anticipated to drive the growth of the aortic endograft market in the foreseeable future. Aortic aneurysms, characterized by abnormal dilation of the aorta, the body's largest artery, are effectively treated using aortic endografts, known for their minimally invasive nature compared to traditional open surgery. These devices, typically composed of fabric-covered metal or polymer, are introduced through a catheter, reinforcing weakened aortic walls and reducing the risk of rupture. Notably, in February 2023, data from the UK-based Government Digital Service revealed that approximately 274,800 men underwent screening, with 79.0% receiving conclusive results and the detection of 1,794 aneurysms between April 2021 and March 2022. This underscores the driving force of the growing prevalence of aortic aneurysms in fostering the expansion of the aortic endograft market.

Key players in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to enhance their competitive position in the industry. The castor-branched aortic stent graft system is a medical device designed for minimally invasive repair of the aorta and aortic arch, particularly for Stanford type B aortic dissection (TBAD). For example, in August 2024, Terumo India, a significant medical technology company and the Indian subsidiary of Terumo Corporation, introduced the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR). This advanced system is intended for treating infrarenal abdominal aortic aneurysms in adults with suitable anatomies and is the only EVAR graft that provides both suprarenal and infrarenal active fixation.

In September 2022, Getinge, a Sweden-based company specializing in medical technology and life sciences equipment, formed a partnership with Medtronic after the CE mark approval for Medtronic's Radiant covered stent. This collaboration is in line with Getinge's strategy to provide comprehensive solutions for complex aortic repair procedures, such as chimney endovascular aneurysm repair (ChEVAR), and aims to offer clinicians a complete package for these advanced treatments. Medtronic, based in Ireland, is a leading player in medical technology and healthcare solutions.

Major companies operating in the aortic endograft market report are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., LifeTech Scientific Corporation, Altura Medical Inc., MicroVention Inc., MicroPort Scientific Corporation, CryoLife Inc., Cordis Corporation, Endologix LLC, Braile Biomedica Industria Comercio e Representacoes Ltda., Nano Endoluminal S.A., Biomerics LLC, JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH

North America was the largest region in the aortic endograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic endograft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aortic endograft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The aortic endograft market consists of revenues earned by entities by training programs, educational services, maintenance, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic endograft market also includes sales of endoanchors and sealants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aortic Endograft Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aortic endograft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aortic endograft ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aortic endograft market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Aortic Endograft Market Characteristics

3. Aortic Endograft Market Trends And Strategies

4. Aortic Endograft Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Aortic Endograft Growth Analysis And Strategic Analysis Framework

6. Aortic Endograft Market Segmentation

7. Aortic Endograft Market Regional And Country Analysis

8. Asia-Pacific Aortic Endograft Market

9. China Aortic Endograft Market

10. India Aortic Endograft Market

11. Japan Aortic Endograft Market

12. Australia Aortic Endograft Market

13. Indonesia Aortic Endograft Market

14. South Korea Aortic Endograft Market

15. Western Europe Aortic Endograft Market

16. UK Aortic Endograft Market

17. Germany Aortic Endograft Market

18. France Aortic Endograft Market

19. Italy Aortic Endograft Market

20. Spain Aortic Endograft Market

21. Eastern Europe Aortic Endograft Market

22. Russia Aortic Endograft Market

23. North America Aortic Endograft Market

24. USA Aortic Endograft Market

25. Canada Aortic Endograft Market

26. South America Aortic Endograft Market

27. Brazil Aortic Endograft Market

28. Middle East Aortic Endograft Market

29. Africa Aortic Endograft Market

30. Aortic Endograft Market Competitive Landscape And Company Profiles

31. Aortic Endograft Market Other Major And Innovative Companies

32. Global Aortic Endograft Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aortic Endograft Market

34. Recent Developments In The Aortic Endograft Market

35. Aortic Endograft Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â